KLRK1 and ovarian carcinoma: Carlsten et al. have shown that NKs derived from healthy donor can recognize and kill in vitro ovarian carcinoma cells, isolated from peritoneal effusions, through the activation of DNAM-1 signaling with complementary contributions of NKG2D and NCR receptors [46].